ArticleScientific reports2025
Relationship of serum phosphorus level with acute cerebrovascular disease.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Systematic review and meta-analysis of stroke blood biomarker data highlights need for more translational research methods.Nature communications · 2026Pooled it
- Essential and Toxic Elements in Cardiovascular Disease: Pathophysiological Roles and the Emerging Contribution of Hair Mineral Analysis.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There are no sufficient studies on laboratory parameters associated with acute stroke. Laboratory parameters associated with acute stroke may become important in the prevention or follow-up of the disease. To investigate the relationship between cerebrovascular disease (CVD) and serum phosphorus levels. This study was conducted prospectively to evaluate the relationship between cerebrovascular disease and phosphorus in patients who applied to the Emergency Medicine Clinic of the Faculty of Medicine Hospital and underwent central imaging between March 1, 2023, and December 31, 2023. 299 patients who applied to the university emergency department were prospectively included in the study with brain computed tomography (CT) and diffusion magnetic resonance imaging (MRI). The lactate, white blood cell, hgb, neutrophil, lymphocyte, urea, creatine and phosphorus values of the patients at their first admission were recorded. The patients were divided into two groups: CVD group and control group. The laboratory parameters of the patients were compared according to the groups. In the ROC analysis performed to evaluate the power of laboratory parameters in predicting the diagnosis of CVD, the AUC value of phosphorus was obtained as 0.935, lactate as 0.620 and urea as 0.596. The optimum cut-off value for phosphorus was calculated as 3.47 (mg/dl) and the sensitivity of this cut-off value was found to be 89%, specifically 86.9%, positive predictive value (ppv) as 77.4% and negative predictive value (npv) as 94%. Lactate, urea and phosphorus values were found to be significantly higher in the CVD group compared to the control group. With this study, we found that serum phosphorus levels were higher than our cut-off value in patients with acute ischemic CVD. We believe that serum phosphorus level will be useful in excluding acute cerebrovascular disease due to its high negative predictive value when evaluated according to the cut-off value of 3.47 (mg/dl).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.